Study suggests more than a third of prostate cancer patients are receiving contraindicated treatment

Author：  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.1, 2008-01, pp. : 13-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Outcome of Overactive Bladder Patients Receiving Antimuscarinic Therapy for More than One Year

By  

LUTS, Vol. 10, Iss. 1, 2018-01 ,pp. : 21-26

John Wiley & Sons Inc

Access to resources Recommend Favorite

ENDORSE study suggests too few hospitalized patients are receiving thromboprophylaxis

By  

Therapy, Vol. 5, Iss. 2, 2008-03 ,pp. : 133-137

Future Medicine

Access to resources Recommend Favorite

Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules

By  

Oncology, Vol. 84, Iss. 2, 2012-11 ,pp. : 92-99

Karger

Access to resources Recommend Favorite

Clinical Significance of Neoadjuvant Combined Androgen Blockade for More Than Six Months in Patients with Localized Prostate Cancer Treated with Prostate Brachytherapy

By  

Urologia Internationalis, Vol. 95, Iss. 4, 2015-0 ,pp. : 457-464

Karger

Access to resources Recommend Favorite

Quality indicators for prostate radiotherapy: Are patients disadvantaged by receiving treatment in a ‘generalist’ centre?

By  

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Vol. 59, Iss. 2, 2015-04 ,pp. : 255-264

John Wiley & Sons Inc

Access to resources Recommend Favorite